M2RLAB, S.L.

Web: http://m2rlab.com

Founding Year: 2021

Industries: biotechnology

Technologies: drug development

Ods: ODS 03: Good Health and Well-being

Business Model: manufacturing

Income Stream: selling own inventory

Business Focus: B2B

Short Description (in English): R&D biotech company developing regenerative therapies for tissue repair and organ function.

Overview (in English): M2RLAB is a biotech company developing innovative therapies to regenerate tissue and organ function by reducing fibrosis and promoting cell proliferation. They focus on modifying leukocyte phenotype to enhance tissue repair, with candidate therapies for kidney failure, muscular injury, and ARDS.